| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 |
| | 10-K | 10-K | 10-K |
| Revenue | 442.4 | 412.8 | 328.8 |
| Revenue growth | 7.2% | 25.6% | |
| Costs and operating expenses: | | | |
| Sales and marketing | 55.9 | 51.4 | 33.3 |
| Product and technology | 70.5 | 74.4 | 44.1 |
| General and administrative | 171.8 | 136.6 | 83.2 |
| Depreciation and amortization | 45.3 | 32.6 | 24.7 |
| Total costs and operating expenses | 581.8 | 498.3 | 346.2 |
| Loss from operations | -139.3 | -85.4 | -17.4 |
| Operating margin | -31.5% | -20.7% | -5.3% |
| |
| Other income (expense): | | | |
| Interest income | 1.9 | 0.1 | 0.1 |
| Interest expense | -2.4 | -27.7 | -31.0 |
| Other (expense) income | 20.2 | 27.0 | -9.7 |
| Total other (expense) income | 39.9 | 25.3 | -40.7 |
| Income tax expense | 0.2 | 2.0 | 1.6 |
| Net loss | -119.5 | -85.1 | -60.5 |
| Net loss attributable to noncontrolling interest in subsidiaries | -0.8 | -0.1 | -0.4 |
| Net loss attributable to Sharecare, Inc. | -118.7 | -85.0 | -60.0 |
| |
| Net Loss per Share | | | |
| Net loss per share attributable to common stockholders, basic (in USD per share) | ($0.34) | ($0.30) | ($0.28) |
| Net loss per share attributable to common stockholders, diluted | ($0.34) | ($0.30) | ($0.28) |
| |
| Weighted-average common shares outstanding, basic (in shares) | 348.1 | 281.0 | 215.1 |
| Weighted-average common shares outstanding, diluted (in shares) | 348.1 | 281.0 | 215.1 |
| |
| Comprehensive loss attributable to Sharecare, Inc. | | | |
| Net loss | -119.5 | -85.1 | -60.5 |
| Foreign currency translation | -0.6 | -1.5 | -0.2 |
| |
| Comprehensive loss | | | |
| Comprehensive loss attributable to noncontrolling interest in subsidiaries | | | |
| Comprehensive loss attributable to Sharecare, Inc. | -119.4 | -86.4 | -59.5 |